Skin Cancer Patients Have Hope
Recently our medical director, Nia Terezakis, MD sent me an article from Aesthetic Dermatology, Titled “Should all skin cancer patients be taking nicotinamide?” Published December 15, 2020 by Lily Talakoub, MD and Naissan O. Wesley, MD
To summarize, the doctors cite some very credible third party clinical studies which support the claim of using 500mg of nicotinamide twice daily for high risk, non-melanoma skin cancer patients to help clear and prevent skin cancers. This dosage amount can also be beneficial to actinic keratosis which is a form of precancerous lesions.
Nicotinamide, also known as vitamin B3 should not be confused with niacinamide, niacin or nicotinic acid.
Nicotinamide should not be used in patients with end-stage kidney disease or chronic liver disease.
If you want to read more technical information, here is a great source on the mechanism of action of Nicotinamide from Memorial Sloan Kettering Cancer Center. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/nicotinamide
Disclaimer: the purpose of this post is not to give medical advice but to only inform the public on the benefits and misuses of topical related issues. Before you begin any kind of treatment, it is highly recommended that you consult your physician. These claims have not been reviewed or tested by the FDA.